Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more efficiently. The
Trxade Group Inc.
-(MEDS)
Get the latest Trxade Group Inc. (MEDS) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
TRxADE HEALTH Inc. (MEDS) Q1 2022 Earnings Call Transcript
TRxADE HEALTH Inc. (NASDAQ: MEDS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Founder, Chairman
Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a widder net loss for the first quarter of 2022 despite a 6%
Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent
Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu
[caption id="attachment_135351" align="alignnone" width="1280"] Image: iStock[/caption] Can you briefly talk about your business model and the value you add to the market?
TRxADE HEALTH, Inc. (MEDS) Q4 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q4 2021 earnings call dated Mar. 28, 2022 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive Officer
Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company's revenues
Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering a web-based
Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year
Image: iStock Give us a quick overview of the company. Trxade is a market platform that caters to the independent pharmacies that
Trxade Health beats on Q3 revenue estimate
Trxade Health Inc (NASDAQ: MEDS) on Monday posted third-quarter revenues of $2.6 million, down year-over-over as a result of non-recurring PPE sales.
TRxADE HEALTH, Inc. (MEDS) Q3 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q3 2021 earnings call dated Oct. 25, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the
Trxade CEO: Will see consistent margins ahead
Shares of Trxade Health Inc (NASDAQ: MEDS) took a beating post the second-quarter results earlier this week as the provider of integrated
TRxADE HEALTH, Inc. (MEDS) Q2 2021 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2021 earnings call dated Jul. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Health adds 195 registered members in Q2
Trxade Health Inc (NASDAQ: MEDS) on Monday posted second-quarter revenues of $1.9 million, down year-over-over as a result of non-recurring PPE sales.
Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare services at
Trxade expects its health passport to be a key post-pandemic reopening tool
Over the past few months, Trxade Group (NASDAQ: MEDS) has been busy in its development lab, creating tools that could enable the
Trxade Group Inc. (MEDS) Q1 2021 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q1 2021 earnings call dated Apr. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) beats market expectations on Q1 revenue
Trxade (NASDAQ: MEDS) on Monday posted a 39% increase in first-quarter revenues to $3.1 million due to higher sales in the Integra
Trxade (MEDS) betting big on its new health passport app
With COVID-19 vaccination taking place on a full-fledged scale across the country, the Joe Biden administration had last month announced its commitment
Trxade Group, Inc. (MEDS) Q4 2020 Earnings Call Transcript
Trxade Group, Inc. (NASDAQ: MEDS) Q4 2020 earnings call dated Mar. 29, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive